San Juan Capistrano, California (CA) Pharmaceuticals Companies

Featured companies
Miss Creations
31251 Calle Del Campo
San Juan Capistrano CA 92675
(949) 661-3158
Michael Murphy Inc
25581 Charro Dr.
San Juan Capistrano CA 92675
(949) 496-5410
Total Health Enhancement Corp
27128 Paseo Espada 1502
San Juan Capistrano CA 92675
(760) 754-0186
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Tahiti Naturel USA Inc
27134 Paseo Espada # 302
San Juan Capistrano CA 92675
(949) 661-4919
Tahiti Naturel Usa Inc
27134 Paseo Espada A302
San Juan Capistrano CA 92675
Total Health Enhancement
27128 Paseo Espada # A1501
San Juan Capistrano CA 92675
(949) 429-1766
Lathina Systems
31473 Rancho Viejo Road
San Juan Capistrano CA 92675
(949) 545-6400
S K Pharmaceuticals Inc
31473 Rancho Viejo Road
San Juan Capistrano CA 92675
(949) 235-5265
Allegro Pharmaceuticals LLC
31473 Rancho Viejo Road
San Juan Capistrano CA 92675
(949) 306-2874
Pampered Porcupine
27514 Calle Arroyo # A
San Juan Capistrano CA 92675
(949) 276-7222
Kingdom Elixir
123 main st
San Juan Capistrano CA 92675
(949) 354-3285

alternative medicine
Whereorg has 15 results under Pharmaceuticals Companies in San Juan Capistrano, CA.

Narrow down the browsing criteria below to see more companies.

Other locations for category Pharmaceuticals


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020